Real-time projections of Ebola outbreak size and duration with and without vaccine use in Équateur, Democratic Republic of Congo |
Dan Kelly, MD, MPH |
Congo (Kinshasa), Congo (Brazzaville) |
|
|
Enabling Better Planned Transitions of Malaria Programming from Global Fund Financing to Domestic Financing |
Sara Fewer |
Eritrea, Ethiopia, Kenya, Malawi, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Afghanistan, Bangladesh, India, Nepal, Brunei, Cambodia, Myanmar, Honduras, Cuba, Haiti |
|
|
Institute for Global Orthopedics and Traumatology (IGOT) |
Richard Coughlin, MD |
Ethiopia, Kenya, Malawi, Mozambique, Rwanda, Seychelles, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Egypt, Morocco, Botswana, Namibia, South Africa, Ivory Coast, Ghana, Liberia, Mali, Niger, Nigeria, Sierra Leone, Kazakhstan, Tajikistan, Uzbekistan, China, Afghanistan, Bangladesh, India, Nepal, Viet Nam, Thailand, Philippines, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Brazil |
|
|
Global Strategies for HIV Prevention |
Arthur Ammann, MD |
Zimbabwe, Congo (Kinshasa), Congo (Brazzaville), Liberia, India |
|
|
Growing Emergency Medicine in Tanzania |
Ellen Weber, MD |
Tanzania, Congo (Kinshasa), Congo (Brazzaville) |
|
|
Viral metagenomics to discover viruses |
Eric Delwart, PhD |
Kenya, Uganda, Congo (Kinshasa), Congo (Brazzaville), Ghana, China, India, Nepal, Brazil |
|
|
The Contribution of Unsafe Blood Transfusion to HIV Transmission in Africa: A Literature Review |
Malika Morar, MS |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo |
|
|
UN Special Envoy for Tuberculosis: Strategic Priorities |
Eric Goosby, MD |
Ethiopia, Kenya, Mozambique, Tanzania, Zambia, Zimbabwe, Angola, Central African Republic, Congo (Kinshasa), Congo (Brazzaville), Lesotho, South Africa, Liberia, Nigeria, Sierra Leone, China, North Korea, Bangladesh, India, Pakistan, Cambodia, Indonesia, Viet Nam, Myanmar, Thailand, Philippines, Russia, Brazil, Papua New Guinea |
|
|
Office of the UN Special Envoy for Tuberculosis |
Eric Goosby, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Central Asia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, South Korea, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Caribbean, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
Health Evaluation, Applied Research, and Development (HEARD) |
Dilys Walker, MD |
Ethiopia, Kenya, Madagascar, Malawi, Mozambique, South Sudan, Uganda, Tanzania, Zambia, Congo (Kinshasa), Congo (Brazzaville), Ghana, Liberia, Mali, Nigeria, Senegal, India, Nepal, Pakistan, Indonesia, Myanmar, Yemen, Haiti |
|
|
PREDICT-2 |
Dean Jamison, PhD |
Kenya, Rwanda, South Sudan, Uganda, Tanzania, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Nigeria, Senegal, Sierra Leone, Togo, Bangladesh, India, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand |
|
|
Congenital Syphilis Elimination Cost-Effectiveness Analysis |
James Kahn, MD, MPH |
Burundi, Comoros, Djibouti, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Tanzania, Zambia, Zimbabwe, Cameroon, Central African Republic, Chad, Congo (Brazzaville), Gabon, Sao Tome and Principe, Sudan, Tunisia, Botswana, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Ivory Coast, Ghana, Guinea, Mali, Nigeria, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Uzbekistan, China, Mongolia, Afghanistan, Bangladesh, India, Maldives, Nepal, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Philippines, Jordan, Oman, Saudi Arabia, Belarus, Czech Republic, Estonia, Germany, Hungary, Lithuania, Macedonia, Moldova, Romania, United Kingdom, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Uruguay, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Trinidad and Tobago, Fiji, Kiribati, Papua New Guinea |
|
|
Global Health Sciences Clinical Scholars Program Immersion Experience |
Christopher Stewart, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Israel, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu |
|
|
Population-based HIV Impact Assessments in Resource-Constrained Settings under the President's Emergency Plan for AIDS Relief (PEPFAR) |
George Rutherford, MD |
Burundi, Ethiopia, Kenya, Malawi, Mozambique, Rwanda, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Botswana, Lesotho, Namibia, South Africa, Swaziland, Ivory Coast, Ghana, Nigeria, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, India, Cambodia, Indonesia, Viet Nam, Laos, Thailand, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Suriname, Antigua and Barbuda, Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Papua New Guinea |
|
|
WHO Adolescent HTC Review Update (PO# 200660799) |
George Rutherford, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, Japan, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
Interventions for Improving Retention in Antiretroviral Therapy (ART) Programs (PO 200988865) |
George Rutherford, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Syria, Turkey, Yemen, Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Montenegro, Slovakia, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Ecuador, Peru, Uruguay, Venezuela, Haiti, Jamaica |
|
|
Systematic reviews to support the Antiretroviral Therapy (ART) Consolidated Guidelines - 2014/HTM/HIV/007 |
George Rutherford, MD |
Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Liberia, Mali, Mauritania, Niger, Nigeria, Sierra Leone, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, South Korea, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Georgia, Iraq, Israel, Jordan, Kuwait, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Bosnia and Herzegovina, Bulgaria, Croatia, Macedonia, Moldova, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Paraguay, Peru, Uruguay, Venezuela, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Dominica, Dominican Republic, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, American Samoa, Northern Mariana Islands, Guam, Fiji, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Vanuatu |
|
|
Implementation of The Global Fund's Programmatic Quality Assurance and Improvement Approach |
George Rutherford, MD |
Burundi, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Lesotho, Benin, Burkina Faso, Gambia, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Sierra Leone, Togo, Kyrgyzstan, North Korea, Afghanistan, India, Nepal, Laos, Syria, Honduras |
|
|
Ebola modeling: behavior, asymptomatic infection, and contacts |
Travis Porco, PhD, MPH |
Congo (Kinshasa), Congo (Brazzaville), Liberia, Sierra Leone |
|
|
University of California Global Health Institute Women's Health and Empowerment Center of Expertise Post-Doctoral Fellowship Program |
Craig Cohen, MD, MPH |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, South Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu |
|
|
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing |
Charles Chiu, MD, PhD |
Congo (Kinshasa), Congo (Brazzaville), Brazil |
|
|
Viral Discovery in Human and Animal Samples |
Charles Chiu, MD, PhD |
Rwanda, Uganda, Tanzania, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Gabon, China, Bangladesh, Nepal, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Thailand, Mexico, Bolivia, Brazil, Peru |
|
|
Clin 0004 Characterization of Viral Hemorrhagic Fevers of Unknown Origin |
Charles Chiu, MD, PhD |
Cameroon, Central African Republic, Congo (Kinshasa), Congo (Brazzaville), Gabon |
|
|
Serological prevalence of viral hemorrhagic fevers in Equatorial Africa |
Charles Chiu, MD, PhD |
Cameroon, Central African Republic, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon |
|
|
Metabiota - Viral Surveillance for the PREDICT Program 20150410 |
Charles Chiu, MD, PhD |
Rwanda, Uganda, Tanzania, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Gabon, China, Bangladesh, Nepal, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Thailand, Mexico, Bolivia, Brazil, Peru |
|
|